PhotothermalPhage: A Virus-Based Photothermal Therapeutic Agent

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Immunology

Background:

• Virus-like particles (VLPs) are versatile nanocarriers mimicking viral structures.
• VLPs offer safe platforms for functionalization and immunization in biomedical applications.

Purpose of the Study:

• To develop a novel immunophotothermal agent for enhanced cancer therapy.
• To create a chemically modified VLP (bacteriophage Qβ) conjugated with near-infrared (NIR) absorbing dyes.

Main Methods:

• Conjugation of croconium dyes to lysine residues on bacteriophage Qβ VLPs to create PhotothermalPhage.
• Evaluation of NIR absorption and heat generation upon 808 nm laser irradiation.
• Assessment of tumor suppression, metastasis reduction, and survival in preclinical models.

Main Results:

• PhotothermalPhage exhibits potent NIR absorption and efficient heat generation, comparable to gold nanostructures.
• The VLP-based agent is biodegradable and possesses inherent immunoadjuvant properties.
• Synergistic effects of photothermal ablation and VLP immunogenicity led to significant primary tumor suppression and reduced lung metastasis.

Conclusions:

• PhotothermalPhage represents a new generation of biodegradable immunophotothermal agents.
• This VLP-based nanocarrier demonstrates significant therapeutic potential for cancer treatment.
• The combined approach enhances anti-tumor immunity and improves overall survival outcomes.